PT Medikaloka Hermina Tbk

IDX:HEAL.JK

1450 (IDR) • At close October 30, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) IDR.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 1,682,2721,637,8461,706,4101,554,2101,538,4281,338,8521,352,5961,310,6071,262,0891,136,3021,192,8121,193,0911,528,7831,513,3711,584,8781,533,2331,150,648748,272983,889943,221899,581886,599901,539769,831772,850769,284746,126714,468681,935640,897640,897
Cost of Revenue 1,157,6321,103,4251,075,6431,103,807955,057882,105846,354889,235831,552765,882706,753719,889764,964734,963704,815706,401584,487446,967543,644559,051500,767484,726460,141408,881444,376451,101400,125393,137404,282378,925.5378,925.5
Gross Profit 524,640534,421630,767450,403583,371456,747506,242421,372430,537370,420486,059473,202763,819778,408880,063826,832566,161301,305440,245384,170398,814401,873441,398360,950328,474318,183346,001321,331277,653261,971.5261,971.5
Gross Profit Ratio 0.3120.3260.370.290.3790.3410.3740.3220.3410.3260.4070.3970.50.5140.5550.5390.4920.4030.4470.4070.4430.4530.490.4690.4250.4140.4640.450.4070.4090.409
Reseach & Development Expenses 0000000000000000000000000000000
General & Administrative Expenses 037,06339,66341,53034,64122,90049,22685,30652,48937,82034,79143,20360,80352,89051,333106,63969,36326,82044,43413,32744,68240,39871,56556,37912,54739,89439,80160,48241,79939,02839,028
Selling & Marketing Expenses 03,7803,7394,0343,3823,1224,1874,9575,3753,9824,3144,7473,0572,9812,3453,4102,4751,8243,2872,5725,3265,0784,9742,8941,42211,3124,4424,564-5585,5245,524
SG&A 285,053253,813299,616286,64838,02326,02253,41390,26357,86441,80239,10547,95063,86055,87153,678110,04971,83828,64447,72115,89950,00845,47676,53959,27313,96951,20644,24365,04641,241154,316.5154,316.5
Other Expenses 02,3502,17814,5109,1064,990263,560203,102259,573221,211279,11297,21112,66820,59010,98112,66521,83221,3389,31411,55310,1175,6344,52418,710-1,9212,4807,5291,817-43300
Operating Expenses 285,053253,813299,616286,648322,225290,218316,973293,365317,437263,013318,217209,463373,906307,051367,539354,107274,511255,496280,232266,476240,027260,432307,133297,356230,213216,182246,280224,118177,279168,939168,939
Operating Income 239,587280,608331,151163,755270,306171,442197,593100,115151,172123,907212,179358,209405,197486,631528,129492,087313,74666,950169,153128,783168,796146,981138,77381,44094,239103,873106,42296,02792,98598,574.598,574.5
Operating Income Ratio 0.1420.1710.1940.1050.1760.1280.1460.0760.120.1090.1780.30.2650.3220.3330.3210.2730.0890.1720.1370.1880.1660.1540.1060.1220.1350.1430.1340.1360.1540.154
Total Other Income Expenses Net -31,445-29,431-26,110-13,600-27,455-27,508-24,140-26,790-26,941-27,281-26,27328,545-15,041-15,389-12,829-8,901-2,045-100-13,141-10,667-2,525-19,807-13,712-1,216-17,699-42,291-26,833-40,419-38,859-23,469-23,469
Income Before Tax 208,142251,177305,041150,155242,851143,934173,45373,325124,23196,626185,906327,667374,872455,968499,695463,824289,60545,709146,872107,027156,262121,634120,55362,37880,56259,71072,88856,79461,51575,105.575,105.5
Income Before Tax Ratio 0.1240.1530.1790.0970.1580.1080.1280.0560.0980.0850.1560.2750.2450.3010.3150.3030.2520.0610.1490.1130.1740.1370.1340.0810.1040.0780.0980.0790.090.1170.117
Income Tax Expense 52,65353,21661,14132,37555,44926,68036,6059,62523,17927,47241,03932,29385,156107,816133,163167,21274,83210,77547,55327,56154,39333,44946,15333,30817,90611,11522,18530,86738,55617,974.517,974.5
Net Income 125,003152,211190,94688,506146,49893,442108,90053,07181,13953,139111,247229,980228,491261,405283,250211,567157,41632,39871,84145,31585,41268,18556,45514,14540,19132,94237,09611,91414,97335,30135,301
Net Income Ratio 0.0740.0930.1120.0570.0950.070.0810.040.0640.0470.0930.1930.1490.1730.1790.1380.1370.0430.0730.0480.0950.0770.0630.0180.0520.0430.050.0170.0220.0550.055
EPS 8.3810.2312.966.0810.116.457.523.675.613.687.6819.9815.4517.6819.1614.3110.652.184.833.055.754.593.80.952.72.612.940.941.193.553.55
EPS Diluted 8.3810.2312.925.7310.076.437.493.655.573.657.6319.9815.4517.6818.9614.3110.652.184.763.055.754.593.770.952.72.612.940.941.193.553.55
EBITDA 466,434483,156483,137392,943342,385248,596243,529151,397183,695138,295271,914400,062430,919517,562547,690504,039323,344110,372198,012145,030201,284174,070172,932131,042131,186136,130135,656132,369146,401180,673.5180,673.5
EBITDA Ratio 0.2770.2950.2830.2530.2230.1860.180.1160.1460.1220.2280.3350.2820.3420.3460.3290.2810.1480.2010.1540.2240.1960.1920.170.170.1770.1820.1850.2150.2820.282